ATE494370T1 - Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren - Google Patents
Vektoren auf transposonbasis und verfahren zur integration von nukleinsäurenInfo
- Publication number
- ATE494370T1 ATE494370T1 AT03748973T AT03748973T ATE494370T1 AT E494370 T1 ATE494370 T1 AT E494370T1 AT 03748973 T AT03748973 T AT 03748973T AT 03748973 T AT03748973 T AT 03748973T AT E494370 T1 ATE494370 T1 AT E494370T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acids
- transposon
- integration
- based vectors
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39862802P | 2002-07-24 | 2002-07-24 | |
PCT/US2003/023090 WO2004009792A2 (en) | 2002-07-24 | 2003-07-24 | Transposon-based vectors and methods of nucleic acid integration |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE494370T1 true ATE494370T1 (de) | 2011-01-15 |
Family
ID=30771227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03748973T ATE494370T1 (de) | 2002-07-24 | 2003-07-24 | Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060210977A1 (de) |
EP (1) | EP1546322B1 (de) |
AT (1) | ATE494370T1 (de) |
AU (1) | AU2003268022B2 (de) |
CA (1) | CA2533708C (de) |
DE (1) | DE60335637D1 (de) |
ES (1) | ES2358994T3 (de) |
SI (1) | SI1546322T1 (de) |
WO (1) | WO2004009792A2 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7527966B2 (en) * | 2002-06-26 | 2009-05-05 | Transgenrx, Inc. | Gene regulation in transgenic animals using a transposon-based vector |
US20040172667A1 (en) | 2002-06-26 | 2004-09-02 | Cooper Richard K. | Administration of transposon-based vectors to reproductive organs |
US20080008687A1 (en) * | 2003-02-10 | 2008-01-10 | Max-Delbruck-Centrum Fur Molekulare Medizin (Mdc) | Transposon-Based Targeting System |
ATE536419T1 (de) * | 2003-02-10 | 2011-12-15 | Max Delbrueck Centrum | Transposon basiertes targeting- system |
DE602004031284D1 (de) * | 2003-02-10 | 2011-03-17 | Max Delbrueck Centrum | Transposon-system zur gezielten integration |
US8071364B2 (en) | 2003-12-24 | 2011-12-06 | Transgenrx, Inc. | Gene therapy using transposon-based vectors |
US20050215507A1 (en) * | 2004-03-04 | 2005-09-29 | Massachusetts Institute Of Technology | Therapeutic anti-cancer DNA |
US7842503B2 (en) | 2004-04-30 | 2010-11-30 | Poetic Genetics, Llc | Hybrid recombinases for genome manipulation |
WO2006078431A2 (en) | 2004-12-22 | 2006-07-27 | The University Of Iowa Research Foundation | Compositions and methods related to modified retroviral vectors for restricted, site specific integration |
US7919583B2 (en) | 2005-08-08 | 2011-04-05 | Discovery Genomics, Inc. | Integration-site directed vector systems |
WO2008100424A2 (en) * | 2007-02-09 | 2008-08-21 | University Of Hawaii | Animals and cells with genomic target sites for transposase-mediated transgenesis |
WO2008137114A1 (en) * | 2007-05-04 | 2008-11-13 | University Of Hawai'i | Methods and compositions for targeted delivery of gene therapeutic vectors |
US20090042297A1 (en) * | 2007-06-01 | 2009-02-12 | George Jr Alfred L | Piggybac transposon-based vectors and methods of nucleic acid integration |
JP2010529862A (ja) * | 2007-06-16 | 2010-09-02 | スカラブ ゲノミクス, エルエルシー | 核酸パッケージングシステム |
CN101503670B (zh) * | 2008-02-04 | 2011-12-14 | 复旦大学附属华山医院 | 一种含有整合子的工程菌株 |
US8309791B2 (en) * | 2008-07-16 | 2012-11-13 | Recombinectics, Inc. | Method for producing a transgenic pig using a hyper-methylated transposon |
WO2010036978A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of growth hormone |
US9150880B2 (en) | 2008-09-25 | 2015-10-06 | Proteovec Holding, L.L.C. | Vectors for production of antibodies |
WO2010085699A2 (en) * | 2009-01-23 | 2010-07-29 | The Johns Hopkins University | Mammalian piggybac transposon and methods of use |
GB2467167B (en) | 2009-01-26 | 2013-09-11 | Algentech Sas | Gene targeting in plants |
WO2010118360A1 (en) | 2009-04-09 | 2010-10-14 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Production of proteins using transposon-based vectors |
CN107312796A (zh) | 2010-12-15 | 2017-11-03 | 大学共同利用机关法人情报·系统研究机构 | 蛋白质的生产方法 |
EP3019618B1 (de) * | 2013-07-12 | 2018-10-31 | University of South Alabama | Minimale piggybac-vektoren für genomische integration |
BR112018005620A2 (pt) * | 2015-09-22 | 2018-10-09 | Univ Wuerzburg J Maximilians | método para transferência de gene estável e de nível elevado em linfócitos |
CN105154473B (zh) * | 2015-09-30 | 2019-03-01 | 上海细胞治疗研究院 | 一种高效安全的转座子整合系统及其用途 |
CN105481984B (zh) * | 2015-12-03 | 2020-09-22 | 上海细胞治疗研究院 | 一种高效介导外源基因整合的转座酶及其用途 |
JP2021519073A (ja) | 2018-03-29 | 2021-08-10 | ジェネンテック, インコーポレイテッド | 哺乳動物細胞におけるラクトジェニック活性の制御 |
KR20210126564A (ko) * | 2019-02-13 | 2021-10-20 | 프로바이오겐 아게 | 향상된 삽입 부위 선택 특성을 지닌 트랜스포사제(transposase) |
BR112021024828A2 (pt) * | 2019-06-11 | 2022-01-25 | Univ Pompeu Fabra | Construtos de edição de gene alvejado e métodos de uso dos mesmos |
EP3835421A1 (de) * | 2019-12-11 | 2021-06-16 | Consejo Superior de Investigaciones Científicas (CSIC) | Vektoren für gewebespezifische transkriptomik |
TW202202620A (zh) | 2020-03-26 | 2022-01-16 | 美商建南德克公司 | 經修飾之哺乳動物細胞 |
CA3173889A1 (en) | 2020-05-04 | 2021-11-11 | Saliogen Therapeutics, Inc. | Transposition-based therapies |
MX2022016453A (es) | 2020-06-24 | 2023-02-01 | Genentech Inc | Lineas celulares resistentes a la apoptosis. |
WO2022012758A1 (en) | 2020-07-17 | 2022-01-20 | Probiogen Ag | Hyperactive transposons and transposases |
CA3215965A1 (en) | 2021-04-19 | 2022-10-27 | Amy Shen | Modified mammalian cells |
JP2024521107A (ja) | 2021-05-21 | 2024-05-28 | ジェネンテック, インコーポレイテッド | 目的の組換え産物を産生するための修飾細胞 |
WO2023039434A1 (en) * | 2021-09-08 | 2023-03-16 | Metagenomi, Inc. | Systems and methods for transposing cargo nucleotide sequences |
KR20240117146A (ko) | 2021-12-22 | 2024-07-31 | 제넨테크, 인크. | 다중 벡터 재조합효소 매개 카세트 교환 |
WO2024068845A1 (en) * | 2022-09-29 | 2024-04-04 | Vib Vzw | New loxpsym sites for large-scale orthogonal cre-mediated recombination |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6225121B1 (en) * | 1992-09-14 | 2001-05-01 | Institute Of Molecular Biology And Biotechnology/Forth | Eukaryotic transposable element |
US6150511A (en) * | 1995-05-09 | 2000-11-21 | Fox Chase Cancer Center | Chimeric enzyme for promoting targeted integration of foreign DNA into a host genome |
AU5741996A (en) * | 1995-05-22 | 1996-12-11 | Chiron Corporation | Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein |
WO1997020038A1 (en) * | 1995-12-01 | 1997-06-05 | The Regents Of The University Of California | Compositions and methods for site-directed integration into dna |
WO1999053017A2 (en) * | 1998-04-15 | 1999-10-21 | Fred Hutchinson Cancer Research Center | Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene |
WO2001030965A2 (en) * | 1999-10-28 | 2001-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of in vivo gene transfer using a sleeping beauty transposon system |
IL154059A0 (en) * | 2000-07-21 | 2003-07-31 | Syngenta Participations Ag | Zinc finger domain recognition code and uses thereof |
US20020132350A1 (en) * | 2000-09-14 | 2002-09-19 | Pioneer Hi-Bred International, Inc. | Targeted genetic manipulation using Mu bacteriophage cleaved donor complex |
EP1308516A1 (de) * | 2001-10-24 | 2003-05-07 | ADEREGEM (Association pour le Développement de la Recherche en Génétique Moléculaire | Zielgerichtete Rekombinase-Fusionsproteine und entsprechende Polynukleotide, Vektoren und Kits, und deren Verwendungen zur zielgerichteten DNS-Rekombination |
-
2003
- 2003-07-24 US US10/521,936 patent/US20060210977A1/en not_active Abandoned
- 2003-07-24 SI SI200331963T patent/SI1546322T1/sl unknown
- 2003-07-24 EP EP03748973A patent/EP1546322B1/de not_active Expired - Lifetime
- 2003-07-24 CA CA2533708A patent/CA2533708C/en not_active Expired - Fee Related
- 2003-07-24 AU AU2003268022A patent/AU2003268022B2/en not_active Ceased
- 2003-07-24 WO PCT/US2003/023090 patent/WO2004009792A2/en not_active Application Discontinuation
- 2003-07-24 ES ES03748973T patent/ES2358994T3/es not_active Expired - Lifetime
- 2003-07-24 AT AT03748973T patent/ATE494370T1/de not_active IP Right Cessation
- 2003-07-24 DE DE60335637T patent/DE60335637D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20060210977A1 (en) | 2006-09-21 |
EP1546322A2 (de) | 2005-06-29 |
AU2003268022A1 (en) | 2004-02-09 |
AU2003268022B2 (en) | 2009-02-05 |
SI1546322T1 (sl) | 2011-05-31 |
WO2004009792A3 (en) | 2004-05-13 |
DE60335637D1 (de) | 2011-02-17 |
EP1546322B1 (de) | 2011-01-05 |
WO2004009792A2 (en) | 2004-01-29 |
CA2533708C (en) | 2013-05-14 |
ES2358994T3 (es) | 2011-05-17 |
EP1546322A4 (de) | 2006-07-19 |
CA2533708A1 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE494370T1 (de) | Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren | |
EP4253551A3 (de) | Neuartige, auf dna und rna gerichtete crispr enzyme und systeme | |
EP4257696A3 (de) | Neuartige, auf dna gerichtete crispr enzyme und systeme | |
PH12021550904A1 (en) | Novel crispr/cas12f enzyme and system | |
WO2007014275A3 (en) | Targeted integration and expression of exogenous nucleic acid sequences | |
WO2005047511A3 (en) | Bacterial expression of protease inhibitors and variants thereof | |
DK1513952T3 (da) | Sammensætninger og fremgangsmåder til frembringelse af nukleinsyre af sputum | |
WO2003080807A3 (en) | Compositions and methods for suppressing eukaryotic gene expression | |
DE602007012858D1 (de) | Verfahren zur durchführung homologer rekombinationen in pflanzen | |
WO2004044181A3 (en) | Antisense modulation of apolipoprotein b expression | |
WO2004002417A3 (en) | Mammalian ch1 deleted mimetibodies, compositions, methods and uses | |
ZA202202628B (en) | Novel crispr dna targeting enzymes and systems | |
DE50311850D1 (de) | Konstrukte und verfahren zur regulation der genexpression | |
MX2007008065A (es) | Composiciones y metodos para modular la expresion genica usando oligonucleotidos autoprotegidos. | |
ATE536415T1 (de) | Klonierung des cytochrome p450 gens von nicotiana | |
WO2003097662A8 (en) | Antisense modulation of apolipoprotein b expression | |
DK1053313T3 (da) | Optimerede antisense oligonucleotider komplementære til DNA methyltransferase-sekvenser | |
WO2001070777A3 (en) | Leafy cotyledon2 genes and their uses | |
EA201070229A1 (ru) | Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения | |
WO2003097810A3 (en) | Nitrilases, nucleic acids encoding them and methods for making and using them | |
WO2004010925A3 (en) | Mammalian genes involved in viral infection and tumor suppression | |
WO2008133749A3 (en) | Antimicrobial agents from microbial genomes | |
ATE420975T1 (de) | Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren | |
DK1766036T3 (da) | Fremgangsmåde til fjernelse af selekterbare markørgensekvenser | |
MXPA02012557A (es) | Composiciones y metodos para la modificacion de la expresion del gen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |